Skip to main content

Athira Pharma, Inc. (NASDAQ: ATHA) Investor Securities Class Action Lawsuit 06/25/2021

  • If you purchased shares of Athira Pharma, Inc. (NASDAQ: ATHA), you may have certain options. Please should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

April 27, 2023 - The parties entered into a stipulation agreement of settlement. July 29, 2022 - The court issued an order granting in part and denying in part the motion to dismiss, leave was given to amend the complaint. March 8, 2022 - A motion was filed to dismiss the consolidated amended complaint. January 7, 2022 - A consolidated amended complaint was filed. June 25, 2021 - An i...



You must register (for free) or login to view the entire case.